Brief: Nextcell Pharma Resolves On Rights Issue Of SEK 40.1 Mln

NextCell Pharma AB

25/04/2024 07:57

April 25(Reuters) - Nextcell Pharma Ab  NXTCL.ST :
    * SAID ON WEDNESDAY BOARD OF DIRECTORS OF NEXTCELL PHARMA
HAS
TODAY RESOLVED ON A NEW ISSUE OF NO MORE THAN 37,817,475 UNITS,
WITH PREFERENTIAL RIGHTS FOR EXISTING SHAREHOLDERS
    * EACH UNIT CONSISTS OF ONE SHARE AND ONE WARRANT OF SERIES
TO2
FREE OF CHARGE
    * UPON FULL SUBSCRIPTION, RIGHTS ISSUE WILL INITIALLY
PROVIDE
NEXTCELL WITH ABOUT SEK 40.1 MILLION, BEFORE DEDUCTION OF ISSUE
COSTS
    * UPON FULL EXERCISE OF THE WARRANTS OF SERIES TO2, THE
COMPANY
MAY RECEIVE AN ADDITIONAL OF UP TO ABOUT SEK 113.5 MILLION
BEFORE DEDUCTION OF ISSUE COSTS
    * RIGHTS ISSUE COVERED TO ABOUT 80% BY GUARANTEE COMMITMENTS
AND
SUBSCRIPTION UNDERTAKINGS AS WELL AS DECLARATIONS OF INTENT
Source text for Workspace:  urn:newsml:reuters.com:*:nWkr5rwf85
Further company coverage:  NXTCL.ST  


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))